PMID: 6981695Oct 1, 1982Paper

Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin

The Journal of Pediatrics
G NolanR Gold

Abstract

The effect of prophylactic antibiotics on bacterial colonization of the respiratory tract and on general progression of cystic fibrosis was studied in a two-year prospective study of 47 mildly to moderately affected patients. One group of patients received inhaled cephaloridine and the other received no inhaled antibiotic; both groups received cloxacillin orally. Carriage of Haemophilus influenzae was greater in the group not receiving inhaled antibiotic (55% vs 20%). Rates of carriage of Staphylococcus aureus (23%). Pseudomonas aeruginosa (greater than 90%). Pseudomonas cepacia (45%), and other organisms were similar in both groups. There were no significant differences between the two groups in incidence of respiratory tract infections or hospital admissions, clinical scores, radiologic scores, or rate of change of pulmonary function. Although continuous antistaphylococcal antibiotic prophylaxis may be successful in suppressing colonization with S. aureus, it may also contribute to the high rates of carriage of Ps. aeruginosa and Ps. cepacia observed in patients with cystic fibrosis.

References

Apr 22, 1976·The New England Journal of Medicine·B H Bowman, J A Mangos
Dec 1, 1972·Archives of Disease in Childhood·M B MearnsR Rushworth
Dec 1, 1972·Archives of Disease in Childhood·J R MayD Thompson
Feb 1, 1972·Archives of Disease in Childhood·D Lawson
Sep 1, 1963·American Journal of Diseases of Children·V F IACOCCAG J BARBERO
Nov 1, 1964·The Journal of Pediatrics·C F DOERSHUKS SPECTOR
Oct 1, 1961·The Journal of Pediatrics·N N HUANGK T SHENG

❮ Previous
Next ❯

Citations

Dec 1, 1987·European Journal of Epidemiology·O C TablanW R Jarvis
Apr 1, 1987·Diagnostic Microbiology and Infectious Disease·C Black-PayneR Silberman
May 1, 1986·The Journal of Pediatrics·D A Goldmann, J D Klinger
Sep 1, 1986·The Journal of Infection·S Glass, J R Govan
Oct 1, 1990·Journal of Medical Microbiology·A R Gessner, J E Mortensen
Apr 9, 2010·Clinical Microbiology Reviews·John J Lipuma
Jun 1, 1993·Archives of Disease in Childhood·J M LittlewoodH Cunliffe
Aug 10, 2007·Thorax·Scott C Bell, Philip J Robinson
Jul 1, 1994·Thorax·D E Stableforth, D L Smith
Dec 1, 1987·The American Review of Respiratory Disease·J S IlowiteG C Smaldone
Feb 19, 2004·American Journal of Respiratory Cell and Molecular Biology·David A GronebergHannelore Daniel
Jul 30, 2009·Expert Opinion on Drug Delivery·Daniela Traini, Paul M Young
Feb 13, 2001·The American Journal of Pathology·D A GronebergA Fischer
Aug 19, 2007·Archivos de bronconeumología·Salvador Bello Dronda, Manuel Vilá Justribó
Jan 26, 2006·European Journal of Pharmacology·Ulrich PisonDavid A Groneberg
Jul 2, 2011·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Christopher H Goss, Marianne S Muhlebach
Dec 24, 2014·International Journal of Antimicrobial Agents·Matthew E FalagasKonstantinos Z Vardakas
Jul 14, 2000·Chest·M GilljamD E Tullis
Sep 24, 1999·Chest·P W Campbell, L Saiman
Mar 4, 2000·The Journal of Pediatrics·J Schneiderman-WalkerJ J Reisman
Sep 1, 1985·Journal of Clinical and Hospital Pharmacy·S R SmithR A Stockley
Jan 1, 1986·Acta paediatrica Scandinavica·A EricssonB Strandvik
May 1, 1986·The Journal of Pediatrics·I MacLuskyF J McLaughlin
May 1, 2015·The Cochrane Database of Systematic Reviews·David K H LoAlan R Smyth
Dec 14, 2012·The Cochrane Database of Systematic Reviews·Gerard RyanTracey Remmington
Jul 22, 2018·The Cochrane Database of Systematic Reviews·David Kh LoAlan R Smyth
Sep 1, 1987·Pediatric Pulmonology·M J ThomassenC F Doershuk
Jun 27, 2002·Paediatric Drugs·Isabelle Sermet-GaudelusGérard Lenoir
Aug 9, 2001·Transplant Infectious Disease : an Official Journal of the Transplantation Society·J J LiPuma
Oct 5, 2006·Current Opinion in Anaesthesiology·Giorgio Della Rocca
Apr 19, 2017·The Cochrane Database of Systematic Reviews·Alan R Smyth, Margaret Rosenfeld
Oct 31, 2018·The Cochrane Database of Systematic Reviews·Sherie SmithEdward Charbek
Jul 15, 2016·The Cochrane Database of Systematic Reviews·Tracey RemmingtonChristian Harkensee
Oct 1, 2020·The Cochrane Database of Systematic Reviews·Margaret RosenfeldAlan R Smyth
Jul 1, 1996·The Annals of Pharmacotherapy·C TosoP G Noone
Apr 3, 2018·The Cochrane Database of Systematic Reviews·Sherie SmithKate H Regan
Apr 1, 1987·Drug Intelligence & Clinical Pharmacy·S A Stout, H Derendorf
May 1, 1985·Anaesthesia·J M Lamberty, B K Rubin
Mar 18, 2011·The Cochrane Database of Systematic Reviews·Gerard RyanKerry Dwan
Jan 1, 1997·Antimicrobial Agents and Chemotherapy·D J TouwD D Briemer
Feb 1, 1984·Journal of Clinical Microbiology·A I McKevitt, D E Woods

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.